Scholay

学术搜索 · AI 审稿 · LaTeX 协作

Li-Ya Chiu

机构：Merck Serono S.p.A. (Italy) · ORCID：0000-0001-9645-7643

发表论文 68 篇 · 总被引 1030 次 · h-index 13

代表论文

  • Selective Inhibition of ATM-dependent Double-strand Break Repair and Checkpoint Control Synergistically Enhances the Efficacy of ATR Inhibitors (2023 · Molecular Cancer Therapeutics · 被引 25)
  • Effect of extended treatment with IAP inhibitor xevinapant post radiotherapy (RT) on efficacy and the tumor microenvironment (TME) in preclinical models. (2023 · Journal of Clinical Oncology · 被引 2)
  • Abstract 2921: Extended treatment with IAP inhibitor xevinapant post radiotherapy improves therapeutic efficacy and promotes antitumor immunity in preclinical models (2024 · Cancer Research · 被引 1)
  • Supplementary Data from Selective Inhibition of ATM-dependent Double-strand Break Repair and Checkpoint Control Synergistically Enhances the Efficacy of ATR Inhibitors (2025)
  • Data from Selective inhibition of ATM-dependent double-strand break repair and checkpoint control synergistically enhances the efficacy of ATR inhibitors (2024)
  • Supplementary Data from Selective inhibition of ATM-dependent double-strand break repair and checkpoint control synergistically enhances the efficacy of ATR inhibitors (2024)